D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 91 Citations 27,678 759 World Ranking 7366 National Ranking 253

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Radiation therapy

The scientist’s investigation covers issues in Radiation therapy, Lung cancer, Nuclear medicine, Internal medicine and Oncology. His Radiation therapy study combines topics in areas such as Positron emission tomography, Prospective cohort study and Cancer. His Lung cancer research integrates issues from Radiation treatment planning, Stage, Surgery, Carcinoma and Primary tumor.

Dirk De Ruysscher interconnects Tomography and Performance status in the investigation of issues within Nuclear medicine. His research links Gastroenterology with Internal medicine. His Oncology research is multidisciplinary, incorporating perspectives in Survival analysis, Hypoxia, Disease and Evidence-based medicine.

His most cited work include:

  • Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (768 citations)
  • Small Cell Lung Cancer (732 citations)
  • Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (724 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Radiation therapy, Internal medicine, Lung cancer, Oncology and Radiology. To a larger extent, he studies Surgery with the aim of understanding Radiation therapy. Dirk De Ruysscher has included themes like Stage, Prospective cohort study, Carcinoma and Randomized controlled trial in his Lung cancer study.

His work carried out in the field of Oncology brings together such families of science as Locally advanced, Clinical trial, Breast cancer and Immunotherapy. His primary area of study in Radiology is in the field of Radiation treatment planning. The Nuclear medicine study which covers Lung that intersects with Radiation induced.

He most often published in these fields:

  • Radiation therapy (49.68%)
  • Internal medicine (43.26%)
  • Lung cancer (43.00%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (43.26%)
  • Oncology (38.51%)
  • Radiation therapy (49.68%)

In recent papers he was focusing on the following fields of study:

His main research concerns Internal medicine, Oncology, Radiation therapy, Lung cancer and Non small cell. Internal medicine is represented through his Chemotherapy, Stage, Prophylactic cranial irradiation, Performance status and Randomized controlled trial research. His Stage research incorporates themes from Chemoradiotherapy and Incidence.

He works mostly in the field of Oncology, limiting it down to topics relating to Cancer and, in certain cases, Prospective cohort study. His Radiation therapy study is associated with Radiology. In his study, Radiosurgery is strongly linked to Quality of life, which falls under the umbrella field of Lung cancer.

Between 2017 and 2021, his most popular works were:

  • Outcome of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors. (59 citations)
  • Definition of Synchronous Oligometastatic Non–Small Cell Lung Cancer—A Consensus Report (54 citations)
  • ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer. (49 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Radiation therapy

Dirk De Ruysscher mostly deals with Internal medicine, Radiation therapy, Lung cancer, Oncology and Radiology. His research investigates the connection with Radiation therapy and areas like Pneumonitis which intersect with concerns in Esophageal cancer. His studies in Lung cancer integrate themes in fields like Chemoradiotherapy, Quality of life and Hazard ratio.

His research in Hazard ratio intersects with topics in Bioelectrical impedance analysis, Surgery, Weakness, Brain metastasis and Mass index. His studies deal with areas such as Cancer, Ipilimumab, Immunotherapy, Clinical trial and Carcinoma as well as Oncology. His Radiology research includes elements of Mastectomy and Occult.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

J. Vansteenkiste;D. De Ruysscher;W.E.E. Eberhardt;E. Lim.
Annals of Oncology (2013)

1177 Citations

Small Cell Lung Cancer

Jan P van Meerbeeck;Dean A Fennell;Dirk K M De Ruysscher.
The Lancet (2011)

952 Citations

Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

M Reck;S Popat;N Reinmuth;Dirk De Ruysscher.
Annals of Oncology (2012)

796 Citations

ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)

Alessandro Brunelli;Anne Charloux;Chris Thomas Bolliger;Gaetano Rocco.
European Respiratory Journal (2009)

754 Citations

Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

M Früh;Dirk De Ruysscher;S Popat;L Crinò.
Annals of Oncology (2013)

581 Citations

The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant

Kobe Reynders;Tim Illidge;Shankar Siva;Shankar Siva;Joe Y. Chang.
Cancer Treatment Reviews (2015)

493 Citations

2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up

J. Vansteenkiste;L. Crinò;C. Dooms;J. Y. Douillard.
Annals of Oncology (2014)

432 Citations

Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach.

Johannes A. Langendijk;Philippe Lambin;Dirk De Ruysscher;Joachim Widder.
Radiotherapy and Oncology (2013)

420 Citations

Time Between the First Day of Chemotherapy and the Last Day of Chest Radiation Is the Most Important Predictor of Survival in Limited-Disease Small-Cell Lung Cancer

Dirk De Ruysscher;Madelon Pijls-Johannesma;Søren M. Bentzen;André Minken.
Journal of Clinical Oncology (2006)

388 Citations

Predicting outcomes in radiation oncology--multifactorial decision support systems

Philippe Lambin;Ruud G. P. M. van Stiphout;Maud H. W. Starmans;Emmanuel Rios-Velazquez.
Nature Reviews Clinical Oncology (2013)

380 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Dirk De Ruysscher

Philippe Lambin

Philippe Lambin

Maastricht University

Publications: 160

Suresh Senan

Suresh Senan

University of Amsterdam

Publications: 146

Matthias Guckenberger

Matthias Guckenberger

University of Zurich

Publications: 72

Johannes A. Langendijk

Johannes A. Langendijk

University Medical Center Groningen

Publications: 70

Hugo J.W.L. Aerts

Hugo J.W.L. Aerts

Brigham and Women's Hospital

Publications: 65

Ben J. Slotman

Ben J. Slotman

University of Amsterdam

Publications: 57

Zhongxing Liao

Zhongxing Liao

The University of Texas MD Anderson Cancer Center

Publications: 51

Egbert F. Smit

Egbert F. Smit

VU University Medical Center

Publications: 48

Benjamin Besse

Benjamin Besse

University of Paris-Saclay

Publications: 47

Patrizia Agostinis

Patrizia Agostinis

KU Leuven

Publications: 45

Ritsuko Komaki

Ritsuko Komaki

The University of Texas MD Anderson Cancer Center

Publications: 41

Joe Y. Chang

Joe Y. Chang

The University of Texas MD Anderson Cancer Center

Publications: 41

Ronald Boellaard

Ronald Boellaard

Amsterdam UMC

Publications: 40

Lorenzo Galluzzi

Lorenzo Galluzzi

Cornell University

Publications: 40

Silvia Novello

Silvia Novello

University of Turin

Publications: 39

Guido Kroemer

Guido Kroemer

Sorbonne University

Publications: 37

Trending Scientists

Begoña Calvo

Begoña Calvo

University of Zaragoza

Zhihong Huang

Zhihong Huang

Hewlett-Packard (United States)

Bettina V. Lotsch

Bettina V. Lotsch

Max Planck Society

Paul C. Painter

Paul C. Painter

Pennsylvania State University

Gerald Earle Jellison Jr

Gerald Earle Jellison Jr

Oak Ridge National Laboratory

Michael Ploug

Michael Ploug

University of Copenhagen

Lluis Fajas

Lluis Fajas

University of Lausanne

Christine Katlama

Christine Katlama

Pitie-Salpetriére Hospital

Mary J. Pantin-Jackwood

Mary J. Pantin-Jackwood

United States Department of Agriculture

Mathew J. Evans

Mathew J. Evans

University of York

Derek W. G. Sears

Derek W. G. Sears

Ames Research Center

Roy L. Mauldin

Roy L. Mauldin

University of Colorado Boulder

Gisela Trommsdorff

Gisela Trommsdorff

University of Konstanz

Dick R. Wittink

Dick R. Wittink

Yale University

Ole Elgström

Ole Elgström

Lund University

Thomas Rauscher

Thomas Rauscher

University of Basel

Something went wrong. Please try again later.